BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28523478)

  • 1. Anti-GPVI Fab SAR264565 effectively blocks GPVI function in ex vivo human platelets under arterial shear in a perfusion chamber.
    Florian P; Wonerow P; Harder S; Kuczka K; Dubar M; Graff J
    Eur J Clin Pharmacol; 2017 Aug; 73(8):949-956. PubMed ID: 28523478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation.
    Mojica Muñoz AK; Jamasbi J; Uhland K; Degen H; Münch G; Ungerer M; Brandl R; Megens R; Weber C; Lorenz R; Siess W
    Thromb Haemost; 2017 Aug; 117(8):1651-1659. PubMed ID: 28569920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Blockade of Glycoprotein VI Promotes Thrombus Disaggregation in the Absence of Thrombin.
    Ahmed MU; Kaneva V; Loyau S; Nechipurenko D; Receveur N; Le Bris M; Janus-Bell E; Didelot M; Rauch A; Susen S; Chakfé N; Lanza F; Gardiner EE; Andrews RK; Panteleev M; Gachet C; Jandrot-Perrus M; Mangin PH
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2127-2142. PubMed ID: 32698684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet collagen receptor Glycoprotein VI-dimer recognizes fibrinogen and fibrin through their D-domains, contributing to platelet adhesion and activation during thrombus formation.
    Induruwa I; Moroi M; Bonna A; Malcor JD; Howes JM; Warburton EA; Farndale RW; Jung SM
    J Thromb Haemost; 2018 Feb; 16(2):389-404. PubMed ID: 29210180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats.
    Li H; Lockyer S; Concepcion A; Gong X; Takizawa H; Guertin M; Matsumoto Y; Kambayashi J; Tandon NN; Liu Y
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1199-205. PubMed ID: 17322098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Inhibition of Human Atherosclerotic Plaque-Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies.
    Jamasbi J; Megens RT; Bianchini M; Münch G; Ungerer M; Faussner A; Sherman S; Walker A; Goyal P; Jung S; Brandl R; Weber C; Lorenz R; Farndale R; Elia N; Siess W
    J Am Coll Cardiol; 2015 Jun; 65(22):2404-15. PubMed ID: 26046734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human platelet glycoprotein VI function is antagonized by monoclonal antibody-derived Fab fragments.
    Lecut C; Feeney LA; Kingsbury G; Hopkins J; Lanza F; Gachet C; Villeval JL; Jandrot-Perrus M
    J Thromb Haemost; 2003 Dec; 1(12):2653-62. PubMed ID: 14675102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoprotein VI is not a Functional Platelet Receptor for Fibrin Formed in Plasma or Blood.
    Zhang D; Ebrahim M; Adler K; Blanchet X; Jamasbi J; Megens RTA; Uhland K; Ungerer M; Münch G; Deckmyn H; Weber C; Elia N; Lorenz R; Siess W
    Thromb Haemost; 2020 Jun; 120(6):977-993. PubMed ID: 32492725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion and activation of human platelets induced by convulxin involve glycoprotein VI and integrin alpha2beta1.
    Jandrot-Perrus M; Lagrue AH; Okuma M; Bon C
    J Biol Chem; 1997 Oct; 272(43):27035-41. PubMed ID: 9341142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcgammaRIIa and induce GPVI ectodomain shedding.
    Al-Tamimi M; Mu FT; Arthur JF; Shen Y; Moroi M; Berndt MC; Andrews RK; Gardiner EE
    Platelets; 2009 Mar; 20(2):75-82. PubMed ID: 19235048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation.
    Mammadova-Bach E; Ollivier V; Loyau S; Schaff M; Dumont B; Favier R; Freyburger G; Latger-Cannard V; Nieswandt B; Gachet C; Mangin PH; Jandrot-Perrus M
    Blood; 2015 Jul; 126(5):683-91. PubMed ID: 25977585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
    Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro.
    Muzard J; Bouabdelli M; Zahid M; Ollivier V; Lacapère JJ; Jandrot-Perrus M; Billiald P
    FEBS J; 2009 Aug; 276(15):4207-22. PubMed ID: 19558491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly potent anti-human GPVI monoclonal antibodies derived from GPVI knockout mouse immunization.
    Matsumoto Y; Takizawa H; Gong X; Le S; Lockyer S; Okuyama K; Tanaka M; Yoshitake M; Tandon NN; Kambayashi J
    Thromb Res; 2007; 119(3):319-29. PubMed ID: 16566959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI Fab fragment in non-human primates without modification of glycoprotein VI expression.
    Ohlmann P; Hechler B; Ravanat C; Loyau S; Herrenschmidt N; Wanert F; Jandrot-Perrus M; Gachet C
    J Thromb Haemost; 2008 Jun; 6(6):1003-11. PubMed ID: 18419749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-GPVI Fab reveals distinct roles for GPVI signaling in the first platelet layer and subsequent layers during microfluidic clotting on collagen with or without tissue factor.
    Zhang Y; Trigani KT; Shankar KN; Crossen J; Liu Y; Sinno T; Diamond SL
    Thromb Res; 2022 Oct; 218():112-129. PubMed ID: 36037547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimeric Glycoprotein VI Binds to Collagen but Not to Fibrin.
    Ebrahim M; Jamasbi J; Adler K; Megens RTA; M'Bengue Y; Blanchet X; Uhland K; Ungerer M; Brandl R; Weber C; Elia N; Lorenz R; Münch G; Siess W
    Thromb Haemost; 2018 Feb; 118(2):351-361. PubMed ID: 29378359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.
    Massberg S; Konrad I; Bültmann A; Schulz C; Münch G; Peluso M; Lorenz M; Schneider S; Besta F; Müller I; Hu B; Langer H; Kremmer E; Rudelius M; Heinzmann U; Ungerer M; Gawaz M
    FASEB J; 2004 Feb; 18(2):397-9. PubMed ID: 14656994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EXP3179 inhibits collagen-dependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism: potential impact on atherothrombosis.
    Grothusen C; Umbreen S; Konrad I; Stellos K; Schulz C; Schmidt B; Kremmer E; Teebken O; Massberg S; Luchtefeld M; Schieffer B; Gawaz M
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1184-90. PubMed ID: 17347483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of human platelet glycoprotein VI-specific IgG autoantibody and its fragments.
    Chu X; Hou M; Peng J; Zhu Y; Zhang F; Ji X; Wang L; Ma D
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):403-7. PubMed ID: 16788317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.